NEW YORK (GenomeWeb) – Becton Dickinson announced today that it has signed a development and global distribution agreement with Euroclone for molecular tests to detect emerging sexually transmitted diseases.

The molecular assays in development will provide an increased likelihood of patients receiving proper diagnoses and therapy whether or not they exhibit symptoms. The assays will also bolster antimicrobial stewardship in clinical laboratories and help institutions comply with European STI screening guidelines.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.